Mayo Clinic CEO announces retirement after nearly a decade at the helm

By Catherine Sturman
President and CEO of Mayo Clinic, Dr John Noseworthy has announced his plans to retire at the end of 2018 after nine years leading the research group...

President and CEO of Mayo Clinic, Dr John Noseworthy has announced his plans to retire at the end of 2018 after nine years leading the research group’s operations and 28 years at the Clinic.

The clinic’s reputation has soared under Dr Noseworthy’s leadership, where it has seen one of the its strongest years with regards to quality and safety, research advancements and clinical practice. It has also completed its $3.76bn, eight-year philanthropic campaign.

“2017 was an extraordinary year for Mayo Clinic, and I look forward to working with our leadership team throughout 2018 to continue to strengthen Mayo Clinic and advance our humanitarian mission,” said Dr Noseworthy.

Mayo’s 2017 annual report, highlights that it has gained over $700mn in income, with a 49% increase in net income from 2016. The clinic has also undergone a significant recruitment drive.

See also

“Dr. Noseworthy’s inspirational and compassionate leadership has guided the organisation from a group of separate clinics and hospitals to a single integrated organisation focused on serving our patients,” added Jeff Bolton, Vice President, Administration, Mayo Clinic.

Samuel Di Piazza, Chair, Mayo Clinic Board of Trustees commented, “During his tenure as CEO, Dr. Noseworthy led Mayo Clinic to focus on key priorities, significantly increase its external visibility and achieve designation as the No. 1 hospital in the nation by U.S. News & World Report in 2016 and 2017.

“Mayo Clinic has consistently advanced its strategic direction under Dr. Noseworthy’s leadership and is well-positioned for continued success in 2018.”

Its new CEO will be announced in August once identified and transition plans are put in place.

Share

Featured Articles

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance